Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (301-310 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine ExposureRosan A van Zoest, Ferdinand W Wit, Katherine W Kooij, et al.
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotypeAndrew D Revell, Dechao Wang, Robin Wood, et al.
Plos Medicine|May 15, 2020
Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort studyCasper Rokx, Jaime F Borjas Howard, Colette Smit, et al.
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
AIDS (London, England)|August 23, 2011
Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicitySaskia M E Vrouenraets, Christoph A Fux, Ferdinand W N M Wit, et al.
Journal of Virus Eradication|March 24, 2018
HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cARTTanya C Do, Stephen J Kerr, Anchalee Avihingsanon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Pageof 51

Showing results (301-310 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine ExposureRosan A van Zoest, Ferdinand W Wit, Katherine W Kooij, et al.
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2016
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotypeAndrew D Revell, Dechao Wang, Robin Wood, et al.
Plos Medicine|May 15, 2020
Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort studyCasper Rokx, Jaime F Borjas Howard, Colette Smit, et al.
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
AIDS (London, England)|August 23, 2011
Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicitySaskia M E Vrouenraets, Christoph A Fux, Ferdinand W N M Wit, et al.
Journal of Virus Eradication|March 24, 2018
HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cARTTanya C Do, Stephen J Kerr, Anchalee Avihingsanon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Pageof 51